Metastatic

Type: Keyphrase
Name: Metastatic
First reported 52 mins ago - Updated 52 mins ago - 1 reports

Confusing race with nationality

Regarding the July 14 front-page article “ Rola altering DNA of pop culture “: Japanese pop culture talents like “Rola,” “Becky” and Jun Hasegawa are Japanese citizens despite being ethnically “half.” The Nationality Law does not recognize half citizens. ... [Published Japan Times - 52 mins ago]
First reported 16 hours ago - Updated 14 hours ago - 1 reports

Gilead's Pipeline Requires MacroGenics' ImmunoOncology Platform (M&A)

Summary Pending data by year-end, we expect GILD to pay above fair value ($48) >100% upside for MGNX, reflecting its scarcity value delivering both immuno-oncology exposure and high-throughput drug development. GILD currently has no drugs in development ... [Published Seeking Alpha - 16 hours ago]
First reported 16 hours ago - Updated 16 hours ago - 1 reports

Trametinib plus dabrafenib for unresectable or metastatic melanoma with BRAF V600E or V600K mutations

, the combination of trametinib and dabrafenib was granted accelerated approval by the US Food and Drug Administration for the treatment of patients with unresectable or... ... [Published Oncology Report - 16 hours ago]
First reported 18 hours ago - Updated 18 hours ago - 1 reports

A New Strain Of Prostate Cancer?

Metastatic hormone resistant prostate cancer (mHRPC) is defined as prostate cancer that has spread from its original location to other parts of the body. One of many options for treating metastatic prostate cancer is hormone therapy, which aims to lower ... [Published BlackDoctor.org - 18 hours ago]
First reported 18 hours ago - Updated 18 hours ago - 1 reports

Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy - Abstract

Numerous biological pathways are affected in renal cell carcinoma and the introduction of targeted agents has improved the survival of patients with advanced and metastatic disease.Durable and long-lasting cure is rarely achieved, and in select cases, ... [Published UroToday - 18 hours ago]
First reported 22 hours ago - Updated 19 hours ago - 2 reports

Halozyme resumes enrolment and dosing of patients under revised protocol with US FDA

US-based pharmaceutical company Halozyme Therapeutics (Nasdaq: HALO) has said it is once again enrolling and dosing patients in its ongoing Phase II trial to evaluate PEGPH20 in patients with pancreatic cancer under the revised clinical protocol agreed ... [Published Pharma Letter - 20 hours ago]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Multi-Center Trial Shows Significant Pain Relief for Spine Cancer Patients Following Targeted Radiofrequency Ablation Treatment

DFINE ® ,Inc ., a market leader in the minimally invasive treatment of spinaldiseases, today announced the publication of a multi-center study in theJuly/August issue of PainPhysician Journal , the official peer-reviewed publication of the AmericanSociety ... [Published WGNT - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 22 2014 - 2 reports

Ark. university awarded $1.5M for cancer research

Researchers at the University of Arkansas have been awarded $1.5 million from the National Cancer Institute at the National Institutes of Health to develop new molecules and biopharmaceuticals that improve a patient's immune response against tumors.The ... [Published KansasCity.com - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 2 reports

Targeted enzyme prodrug therapy for metastatic prostate cancer – a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase

1 Bioengineering Center and the School of Chemical, Biological and Materials Engineering, University of Oklahoma, Norman, OK, USA2 Oncology-Hematology Section, Health Sciences Center, University of Oklahoma, Oklahoma City, OK, USA3 Stephenson Cancer Center, ... [Published BMC - Jul 22 2014]
Entities: Cytosine, Purine, Nucleoside
First reported Jul 21 2014 - Updated Jul 22 2014 - 2 reports

Vaccine Combo Gains ‘Breakthrough Therapy’ Status for Treatment of Pancreatic Cancer

Immunotherapy prolongs survival in mid-stage trialThe FDA has granted a “breakthrough therapy” designation for an investigational pancreatic cancer combination treatment consisting of GVAX Pancreas and CRS-207 immunotherapies (Aduro Biotech, Inc.).According ... [Published PT Community - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 2 reports

Cancer patient died after two-year delay

Photo / 123RFA breast cancer patient died after a delay of nearly two years in informing her of her positive test results.In October 2009 a woman had a mastectomy performed by a breast surgeon at a private breast clinic, and following this the surgeon ... [Published New Zealand Herald - Jul 21 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Forum Post: RE: Grandma has metastatic brain cancer

RE: Grandma has metastatic brain cancerFamily and friendsIf a member of your family or a friend, or someone else you know is living with cancer, this group is the place to share your feelings and get support.Grandma has metastatic brain cancerPosted by ... [Published Macmillan Cancer Support - Jul 21 2014]

Quotes

...up to 70 per cent of breast cancers," explains Professor Geoff Lindeman from the Walter and Eliza Hall Institute of Medical Research in Melbourne. "We have shown that breast tumours that have high levels of Bcl-2 respond well to treatment with ABT-737 when used in combination with a conventional chemotherapy drug."
...Bliss Professor of Biostatistics at Yale School of Public Health and professor at the Yale Child Study Center and the Department of Statistics. "The study is a great success for multidisciplinary collaboration and teamwork."
"In orthopaedics, we want to restore function to take away pain and to help patients return to activity" said orthopaedic surgeon and lead study author Robert H Brophy
...to restore function to take away pain and to help patients return to activity," said orthopaedic surgeon and lead study author Robert H Brophy, MD. "We're still learning about how to best use, quantify and measure activity levels to optimize prognostics and outcomes."

More Content

All (1928) | News (1523) | Reports (0) | Blogs (360) | Audio/Video (1) | Fact Sheets (2) | Press Releases (25)
sort by: Date | Relevance
Confusing race with nationality [Published Japan Times - 52 mins ago]
A Reverse Approach to Cancer Cell Identification [Published European Medical Device Technology - 1 hour ago]
Understanding the Treatment Options for Thyroid... [Published Record Delta - 1 hour ago]
Melanoma combination therapy study shows promis... [Published Dermatology Times - 2 hours ago]
Branded and Targeted Treatments Driving Almost ... [Published Pressat - 2 hours ago]
NICE ‘yes’ for cancer drugs [Published Pharmafocus - 2 hours ago]
Health: Breast cancer breakthroughs [Published Body And Soul - 5 hours ago]
Biomarker For Inner Ear Stem Cells Found [Published Asian Scientist - 5 hours ago]
Integrative Health [Published Cincy - The Magazine for Business Professionals - 6 hours ago]
Refunded Research Center at Yale Makes Discover... [Published Noodls - 9 hours ago]
Metastatic Urothelial Carcinoma of the Prepuce ... [Published Sexual Development - 10 hours ago]
Prostate cancer Predicting response to androgen... [Published BioPortfolio - 10 hours ago]
Combined MEK, BRAF Inhibitors Promising in Mela... [Published Cancernetwork.com - 11 hours ago]
Cancer survivor advocates for more patient invo... [Published Wiscasset Newspaper - 14 hours ago]
Taiwan Business Quick Take [Published Taipei Times Online - 14 hours ago]
Cancer survivor believes in miracles [Published Beloit Daily News - 14 hours ago]
FDA Grants Priority Review to Bevacizumab (Avas... [Published PT Community - 14 hours ago]
Activity Level May Predict Orthopaedic Outcomes... [Published TheStreet.com - 15 hours ago]
Activity level may predict orthopedic outcomes [Published EurekAlert! - 15 hours ago]
Ganymed Completes Recruitment for Gastroesophag... [Published Drug Discovery and Development - 15 hours ago]
Top Drugs of 2013 [Published Pharmacy Times - 16 hours ago]
Gilead's Pipeline Requires MacroGenics' ImmunoO... [Published Seeking Alpha - 16 hours ago]
Trametinib plus dabrafenib for unresectable or ... [Published Oncology Report - 16 hours ago]
FDA Grants Priority Review again to Avastin—for... [Published Oncology Times - 17 hours ago]
Cytoreductive nephrectomy can benefit patients ... [Published MedWire News - 18 hours ago]
Alternative sunitinib treatment schedules for m... [Published MedWire News - 18 hours ago]
A New Strain Of Prostate Cancer? [Published BlackDoctor.org - 18 hours ago]
Role of metastasectomy for metastatic renal cel... [Published UroToday - 18 hours ago]
New Cancer Treatment Receives "Breakthrough" De... [Published Clawson Patch - 19 hours ago]
Halozyme resumes enrolment and dosing of patien... [Published Pharma Letter - 20 hours ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Pancreatic Cancer - 2014 update from Am Fam Phy... [Published Clinical Cases and Images: CasesBlog - Jul 22 2014]
Pancreatic cancer remains the fourth leading cause of cancer-related deaths in the United States. Risk factors include:- family history- smoking- chronic pancreatitis- obesity- diabetes mellitus- heavy alcohol use- possible dietary factors Symptoms ...
The false hope of “right-to-try” metastasizes t... [Published Science-Based Medicine - Jul 21 2014]
Ed. note: Please read disclaimer in Dr. Gorski’s profile ! There are times when supporting science-based health policy and opposing health policies that sound compassionate but are not are easily portrayed as though I’m opposing mom, apple pie, ...
Lanreotide in Metastatic Enteropancreatic Neuro... [Published NEJM Most Viewed Articles - Week - Jul 20 2014]
Lanreotide in Metastatic Enteropancreatic Neuro... [Published NEJM Most Emailed Articles - Jul 19 2014]
Immunotherapy for Kidney Cancer [Published News from Kidney Cancer Association - Jul 19 2014]
Joseph I. Clark, MD Immunotherapy, a type of treatment designed to enhance or restore the body’s ability to fight cancerous cells by activating the immune system, has long been a mainstay of treatment for kidney cancer, and continues to attract ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
The Fault In Our Stars [Published Slate Magazine - Jun 07 2014]
1

Press Releases

sort by: Date | Relevance
Galectin Therapeutics Announces First Patient D... [Published GlobeNewswire: Acquisitions News - 23 hours ago]
Seragon Pharmaceuticals Announces Acquisition A... [Published GlobeNewswire: Acquisitions News - Jul 02 2014]
Treatment With AGS-003 and Sunitinib Associated... [Published GlobeNewswire: Advertising News - Jun 02 2014]
Karyopharm Updates Data for Selinexor in Solid ... [Published GlobeNewswire: Advertising News - Jun 02 2014]
Immunomedics Reports Final Efficacy Results of ... [Published GlobeNewswire: Advertising News - Jun 01 2014]
1 2 3 4 5
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.